[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK0649425T3 - Pyridino-, pyrrolidino- og azepino-substituerede oximer, som er anvendelige som anti-atherosklerose- og anti-hypercholester - Google Patents

Pyridino-, pyrrolidino- og azepino-substituerede oximer, som er anvendelige som anti-atherosklerose- og anti-hypercholester

Info

Publication number
DK0649425T3
DK0649425T3 DK93912362T DK93912362T DK0649425T3 DK 0649425 T3 DK0649425 T3 DK 0649425T3 DK 93912362 T DK93912362 T DK 93912362T DK 93912362 T DK93912362 T DK 93912362T DK 0649425 T3 DK0649425 T3 DK 0649425T3
Authority
DK
Denmark
Prior art keywords
atherosclerosis
substituted
oxymers
hypercholester
azepino
Prior art date
Application number
DK93912362T
Other languages
Danish (da)
English (en)
Inventor
Charles H Spilman
Scott D Larsen
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK0649425T3 publication Critical patent/DK0649425T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK93912362T 1992-06-17 1993-05-05 Pyridino-, pyrrolidino- og azepino-substituerede oximer, som er anvendelige som anti-atherosklerose- og anti-hypercholester DK0649425T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90022992A 1992-06-17 1992-06-17
PCT/US1993/004059 WO1993025553A1 (en) 1992-06-17 1993-05-05 Pyridino-, pyrrolidino- and azepino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents

Publications (1)

Publication Number Publication Date
DK0649425T3 true DK0649425T3 (da) 1999-09-27

Family

ID=25412199

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93912362T DK0649425T3 (da) 1992-06-17 1993-05-05 Pyridino-, pyrrolidino- og azepino-substituerede oximer, som er anvendelige som anti-atherosklerose- og anti-hypercholester

Country Status (13)

Country Link
US (3) US5565468A (de)
EP (1) EP0649425B1 (de)
JP (1) JPH07507796A (de)
CN (1) CN1081678A (de)
AT (1) ATE177426T1 (de)
AU (1) AU4293393A (de)
DE (1) DE69323883T2 (de)
DK (1) DK0649425T3 (de)
ES (1) ES2130269T3 (de)
GR (1) GR3029946T3 (de)
IL (1) IL105693A0 (de)
MX (1) MX9303594A (de)
WO (1) WO1993025553A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI312347B (en) 2001-02-08 2009-07-21 Eisai R&D Man Co Ltd Bicyclic nitrogen-containing condensed ring compounds
HUP0401292A3 (en) * 2001-04-27 2011-01-28 Eisai R & D Man Co Pyrazolo[1,5-a]pyridines, pharmaceutical compositions containing the same and process for preparation thereof
US7087626B2 (en) * 2001-05-24 2006-08-08 Eli Lilly And Company Pyrrole derivatives as pharmaceutical agents
CA2494574C (en) * 2002-10-22 2011-05-17 Eisai Co., Ltd. 7-phenylpyrazolopyridine compounds
US7176216B2 (en) * 2002-10-22 2007-02-13 Eisai Co., Ltd. 7-phenylpyrazolopyridine compounds
WO2007008529A2 (en) * 2005-07-08 2007-01-18 Kalypsys, Inc Celullar cholesterol absorption modifiers
US7501438B2 (en) 2006-07-07 2009-03-10 Forest Laboratories Holdings Limited Pyridoimidazole derivatives
AU2008273050A1 (en) * 2007-07-11 2009-01-15 Auckland Uniservices Limited Pyrazolo[1,5-a]pyridines and their use in cancer therapy
NZ588376A (en) * 2008-04-15 2011-06-30 Eisai R&D Man Co Ltd 3-phenylpyrazolo[5,1-b]thiazole compound having antagonism against corticotropin-releasing factor (CRF) receptor
JPWO2011043387A1 (ja) * 2009-10-08 2013-03-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピラゾロオキサゾール化合物
AR078521A1 (es) * 2009-10-08 2011-11-16 Eisai R&D Man Co Ltd Compuesto pirazolotiazol
WO2015123437A1 (en) 2014-02-13 2015-08-20 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
EP3105219B9 (de) 2014-02-13 2018-10-03 Incyte Corporation Cyclopropylamine als lsd1-hemmer
TWI720451B (zh) 2014-02-13 2021-03-01 美商英塞特控股公司 作為lsd1抑制劑之環丙胺
KR102421235B1 (ko) 2014-02-13 2022-07-15 인사이트 코포레이션 Lsd1 저해제로서 사이클로프로필아민
CN103980281B (zh) * 2014-05-27 2016-06-08 天津市斯芬克司药物研发有限公司 一种咪唑吡嗪化合物及其制备方法
US9758523B2 (en) 2014-07-10 2017-09-12 Incyte Corporation Triazolopyridines and triazolopyrazines as LSD1 inhibitors
US9695180B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
WO2016007731A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyridines and imidazopyrazines as lsd1 inhibitors
US9695167B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors
KR102659373B1 (ko) 2015-04-03 2024-04-23 인사이트 홀딩스 코포레이션 Lsd1 저해제로서 헤테로사이클릭 화합물
EP3334709A1 (de) 2015-08-12 2018-06-20 Incyte Corporation Salze eines lsd1-hemmers
CA3021678A1 (en) 2016-04-22 2017-10-26 Incyte Corporation Formulations of an lsd1 inhibitor
US10968200B2 (en) 2018-08-31 2021-04-06 Incyte Corporation Salts of an LSD1 inhibitor and processes for preparing the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1600969A (en) * 1977-01-07 1981-10-21 Acf Chemiefarma Nv Heterocyclic compounds
US4352804A (en) * 1978-07-25 1982-10-05 Acf Chemiefarma Nv Oxime ethers, their preparation and pharmaceutical compositions containing them
US4925849A (en) * 1987-06-15 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutically useful pyrazolopyridines

Also Published As

Publication number Publication date
EP0649425B1 (de) 1999-03-10
DE69323883T2 (de) 1999-07-22
ES2130269T3 (es) 1999-07-01
ATE177426T1 (de) 1999-03-15
IL105693A0 (en) 1993-09-22
US5523318A (en) 1996-06-04
WO1993025553A1 (en) 1993-12-23
DE69323883D1 (de) 1999-04-15
MX9303594A (es) 1994-01-31
GR3029946T3 (en) 1999-07-30
US5565468A (en) 1996-10-15
AU4293393A (en) 1994-01-04
EP0649425A1 (de) 1995-04-26
CN1081678A (zh) 1994-02-09
US5597816A (en) 1997-01-28
JPH07507796A (ja) 1995-08-31

Similar Documents

Publication Publication Date Title
DK0649425T3 (da) Pyridino-, pyrrolidino- og azepino-substituerede oximer, som er anvendelige som anti-atherosklerose- og anti-hypercholester
IL126038A0 (en) Novel benzothiepines and derivatives thereof and pharmaceutical compositions comprising them
IS4185A (is) Hliðstæð aðferð til framleiðslu fenýlsúlfonylamino-pýrimidines afleiða
ATE167476T1 (de) Substituierte 2-phenyl-3-methocypropensäurenester als fungizide mittel.
KR950700894A (ko) 탁솔 유도체(Taxol derivatives)
GB9003939D0 (en) Sulphatase inhibitors
ATE126215T1 (de) Anti-entzündende 4-aminophenol-derivate.
BG104117A (en) Universally applicable blood plasma
DK0596838T3 (da) Estere af L-carnitin og alkanoyl-L-carnitiner med glycolsyre eller estere deraf og farmaceutiske præparater indeholdende samme til behandling af dermatoser
ES2072784T3 (es) Benzo- y piridopiridonas substituidas con sulfonilbencilo.
BG101002A (en) Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria
ES2090177T3 (es) Derivados de pirrol.
MC2226A1 (fr) Oxetannones
TR199701298T1 (xx) Tetralinler.
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
SE9402241D0 (sv) Inhibitor
AU5994696A (en) Modified alpha-d-glcp-(1-2)-alpha-d-glcp-(1-3)-alpha-d-glcp- analogues
MX9606295A (es) Tiopiridinas para el combate de bacterias heliobacter.
DK1032580T3 (da) Fremgangsmåde til N-desmethylering af erythromyciner og derivater deraf
PL312966A1 (en) Derivatives of thiocarbamoil
MX9800053A (es) Herbicidas de cis-2,3-expoxicicloalcanol bencilado.
RU1809521C (ru) Генератор плазмы
AU8497191A (en) Compositions and methods for treating hiv infections
FI963783A0 (fi) Hypokolesteroleemisiä, antiateroskleroottisia ja hypotriglyserideemisiä aminoasetyylimerkaptojohdannaisia
IT1255470B (it) Composti attivi come inibitori dell'enzima hmg-coa reduttasi